EUVIMEDEUVIMED entdecken
Kohortenstudie

Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study

Xihan Xiang, Xunxi Lu, Mengting He, Zongchao Gou

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2025.02.001 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Xihan Xiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Breast Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy, Lymph Node Excision. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Cancer Institute, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Surgical management of the axilla with neoadjuvant treatment has been a significant research focus over the past decade, resulting in numerous publications. The trends in surgical choices based on lymph node status and survival outcomes in large populations were previously unclear. METHODS: Breast cancer patients who underwent neoadjuvant therapy were identified from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2021 and categorized into 2 cohorts: LN- (no lymph node metastasis) and LNm (1-2 sentinel node metastases). We analyzed the trends in surgical axillary staging and compared the 10-year overall survival between sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND). RESULTS: Among 26,320 patients, 18,548 were in the LN- cohort (16,607 with SLNB and 1,941 with ALND) and 7,772 were in the LNm cohort (3,601 with SLNB and 4,171 with ALND). The proportion of patients undergoing SLNB increased from 76.4% in 2010 to 93.8% in 2021 in the LN- cohort and doubled from 25.2% in 2010 to 55.0% in 2021 in the LNm cohort. ALND was identified as a favorable factor over SLNB in the LNm cohort (hazard ratio [HR] 0.84; 95% CI, 0.73-0.96; P = .014). CONCLUSION: Omission of ALND for patients with 1 to 2 node metastases after neoadjuvant therapy has doubled since 2010. SLNB is an efficient and safe approach of surgical axillary staging for the LN- cohort but not for patients with residual axillary cancer, even with low-volume disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoadjuvant TherapySentinel Lymph Node BiopsyLymph Node ExcisionLymph NodesHumansFemaleAxillaMiddle AgedNeoplasm StagingSEER ProgramLymphatic MetastasisAgedAdultSurvival RateFollow-Up StudiesPrognosisRetrospective StudiesCohort Studies

Stichwörter der Autor:innen

Axillary lymph node dissectionAxillary surgeryNeoadjuvant treatmentOverall survivalSentinel lymph node biopsy

Autor:innen und Institutionen

  • Breast Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Breast Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: fdchao@126.com.

Förderung

  • National Natural Science Foundation of China
  • National Cancer Institute
  • Sichuan University
  • West China Hospital of Sichuan University

Zitieren

APA

Xiang, X., Lu, X., He, M., & Gou, Z. (2025). Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.02.001

Vancouver

Xiang X, Lu X, He M, Gou Z. Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.02.001

BibTeX
@article{Xiang2025,
  author = {Xiang, Xihan and Lu, Xunxi and He, Mengting and Gou, Zongchao},
  title = {Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2025.02.001}
}
Kostenlos starten →